TITLE

The Advanced Breast Biopsy Instrumentation (ABBI) Experience at a Community Hospital

AUTHOR(S)
Sheth, Dharti; Wesen, Cheryl A.
PUB. DATE
August 1999
SOURCE
American Surgeon;Aug1999, Vol. 65 Issue 8, p726
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The Advanced Breast Biopsy Instrumentation (ABBI; U.S. Surgical Corp., Norwalk, CT) system is the newest technology available for the evaluation and diagnosis of nonpalpable breast lesions. It requires the breast imaging specialist, often a radiologist, to localize the suspicious lesion to x, y, and z coordinates in a digital mammogram unit. The coordinates are then used by the surgeon to operate and direct the ABBI biopsy device around the lesion to obtain an excisional biopsy. Mammographic confirmation of the specimen is then immediately obtained. First introduced in the United States in April 1996, the ABBI system is aimed at rivaling the previously relied upon methods of needle-localized and core needle breast biopsies. In this study, we analyzed the first 15 months of use of the ABBI system in a community hospital to evaluate its applicability and efficacy in the diagnosis of nonpalpable breast lesions. Eighteen surgeons and three radiologists performed a total of 230 cases on 223 patients (seven patients had bilateral breast biopsies). The lesions biopsied included 114 clustered microcalcifications, 115 masses, and 1 retained guidewire from a previous needle-localized breast biopsy. The average time for the complete procedure was 65 minutes. Breast cancer was identified in 36 patients (36 of 230, 15.7%) and 1 additional patient had an incidental finding of lobular carcinoma in situ. The malignancies included 20 cases of invasive ductal carcinoma, 12 cases of ductal carcinoma in situ, and four cases of invasive lobular carcinoma. Overall, 84 per cent of the patients had a definitive benign diagnosis and required no further surgical treatment of their mammographic finding. There have been no known missed lesions after use of the ABBI procedure. In conclusion, our experience has shown the ABBI system to be a valuable option in the management of selected patients with nonpalpable breast lesions.
ACCESSION #
2106104

 

Related Articles

  • Sentinel node biopsy in breast cancer. Dixon, Michael // BMJ: British Medical Journal (International Edition);08/01/98, Vol. 317 Issue 7154, p295 

    Editorial. Comments on the use of the sentinel node biopsy in breast cancer treatment in Great Britain. Details on the status of the auxillary lymph nodes in a woman with breast cancer; Details on the findings of studies of sentinel nodes.

  • Metastatic breast carcinoma presenting as cholecystitis. Crawford, David L.; Yeh, I-Tien // American Surgeon;Sep1996, Vol. 62 Issue 9, p745 

    Discusses two cases of metastatic breast cancer presenting as cholecystitis. Biopsy of the gallbladder removed during cholecystectomy; Diagnosis of a metastatic infiltrating ductal carcinoma in one patient and infiltrating lobular carcinoma in the other.

  • Ultrasound evaluation of breast lesions.  // USA Today Magazine;Oct96, Vol. 125 Issue 2617, p6 

    States that high-resolution, digital ultrasound can evaluate more effectively which breast lumps require a biopsy to learn if they are cancerous. Details of a study involving fourteen breast centers in the United States, Canada, and Europe.

  • Test for breast cancer shows promise. Wise, Jacqui // BMJ: British Medical Journal (International Edition);08/08/98, Vol. 317 Issue 7155, p368 

    Reports on the development of a non-invasive test for breast cancer which can help to reduce the number of biopsies for women with benign breast disease. What the test is based on; Information on a study carried out; Insight on an analysis of the findings; Comments from Professor Ian Fentiman,...

  • Diagnostic difficulty arising from displaced epithelium after core biopsy in intracystic papillary lesions of the breast. Douglas-Jones, A.G.; Verghese, A. // Journal of Clinical Pathology;Oct2002, Vol. 55 Issue 10, p780 

    This study reports two cases of intracystic papillary carcinoma of the breast, which had been biopsied preoperatively using a 14 gauge (14G) core biopsy needle. In each case, a needle tract containing groups of epithelial cells within granulation tissue could be identified on histology of the...

  • P63 staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. Reis-Filho, J.S.; Milanezi, F.; Amendoeira, I.; Albergaria, A.; Schmitt, F.C. // Journal of Clinical Pathology;Dec2002, Vol. 55 Issue 12, p936 

    Aims: One of the limitations of fine needle aspiration biopsy (FNAB) of the breast is in distinguishing invasive carcinoma (IDC) from ductal carcinoma in situ (DCIS). It has been proposed that the presence of myoepithelial cells overlying epithelial malignant cell clusters suggests DCIS....

  • Evidence building for low-invasive biopsy.  // Medical Device Daily;2/5/2010, Vol. 14 Issue 24, p8 

    The article focuses on a report published by the U.S. Agency for Healthcare Research and Quality which suggests that low-invasive means of drawing biopsy samples for suspected breast cancer masses is performing at levels that are much closer to surgically resected samples than in the past.

  • 'would have another MAMMOGRAM?'. Sullivan, Dana // Shape;Oct2002, Vol. 22 Issue 2, p188 

    Narrates experience of a woman with breast cancer. Recommendation on surgical biopsy of the breast; Effectiveness of mammography in detecting breast cancer; Detection of microcalcifications on mammograms.

  • New Ways to Diagnose Breast Lumps. Benjamin, Caren // Self;Dec99, Vol. 21 Issue 12, p96 

    Presents ways to diagnose breast lumps. How fine-needle aspiration is done; Advantages of core-needle biopsy; Disadvantages of advanced breast biopsy instrumentation.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics